Skip to content

Impairment of Reading Ability in Dry Eye Patients

Functional Impairment of Reading Ability in Dry Eye Patients and Effects of Sustained Reading on the Ocular Surface

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01826812
Enrollment
200
Registered
2013-04-09
Start date
2013-04-30
Completion date
2015-11-30
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndromes

Brief summary

To assess the reading function impairment in patients with dry eye and to assess the effects of reading on the ocular surface.

Detailed description

This study is being done to understand how reading is affected in people with dry eye in comparison with healthy controls and what effect reading has on the ocular surface in patients with dry eye.

Interventions

OTHER30 minutes sustained reading

The participants will be given a text to read silently in 30 minutes.

OTHERDry eye exam

Tear break-up time, tear collection, osmolarity, Schirmer test, corneal and conjunctival staining.

Sponsors

Allergan
CollaboratorINDUSTRY
Johns Hopkins University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age of 50 or greater, * literacy in English language, * ability to give informed consent

Exclusion criteria

* binocular vision below 20/25, * any ocular surgery within the last 3 months, * mental issues, * illiteracy, * language problems which might possibly interfere with reading ability, * history of taking or current use of topical prescription anti-inflammatory eye drops (including, cyclosporine and steroids as well as any glaucoma eye drops).

Design outcomes

Primary

MeasureTime frame
Sustained Silent Reading Speed30 minutes

Secondary

MeasureTime frameDescription
Change in Total Ocular Staining Score (OSS)Before and after 30 minutes readingOcular staining score (OSS) is sum of the corneal and conjuctival staining scores with a total possible maximum score of 12 for each eye. Corneal staining is graded with a maximum possible fluorescein score of 6 for each cornea (the punctate epithelial erosions grade between 0-3 plus any extra points for modifiers up to 3). Nasal and temporal conjunctiva are graded separately with a score range between 0 and 3 for each area after instillation of lissamine green. An abnormal OSS is defined as being a total score of 3 or more.
Change in Tear OsmolarityBefore and after 30 minutes reading
Change in Visual Acuity30 minutes
CytokinesTear samples were collected on the day of the exam. The samples were frozen to be assayed upon completion of the study.Identification of various inflammatory cytokines in tear film of dry eye patients comparing to controls.

Countries

United States

Participant flow

Pre-assignment details

Ocular staining score (OSS) is sum of the corneal and conjuctival staining scores with a total possible maximum score of 12 for each eye. Corneal staining is graded with a maximum possible fluorescein score of 6 for each eye. Nasal and temporal conjunctiva are graded separately with a lissamine green staining score between 0 and 3 for each area.

Participants by arm

ArmCount
Dry Eye
Dry eye defined as OSDI score more than 12 and/or total OSS score 3 and more
167
Controls
Controls defined as OSDI 12 and less AND total OSS score less than 3
33
Total200

Baseline characteristics

CharacteristicDry EyeTotalControls
Age, Continuous64.1 years
STANDARD_DEVIATION 8.7
63.7 years
STANDARD_DEVIATION 8.3
61.4 years
STANDARD_DEVIATION 8.7
Baseline Osmolarity312 mOsm/L
STANDARD_DEVIATION 28
311 mOsm/L
STANDARD_DEVIATION 26
306 mOsm/L
STANDARD_DEVIATION 10
Baseline total OSS score4.9 scores on a scale of 0 to 12
STANDARD_DEVIATION 3.3
4.3 scores on a scale of 0 to 12
STANDARD_DEVIATION 3.4
0.9 scores on a scale of 0 to 12
STANDARD_DEVIATION 0.9
Baseline Visual Acuity, logMAR-0.04 logMAR
STANDARD_DEVIATION 0.11
-0.038 logMAR
STANDARD_DEVIATION 0.11
-0.03 logMAR
STANDARD_DEVIATION 0.1
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants8 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
160 Participants192 Participants32 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Asian
5 Participants6 Participants1 Participants
Race (NIH/OMB)
Black or African American
17 Participants23 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants6 Participants1 Participants
Race (NIH/OMB)
White
139 Participants163 Participants24 Participants
Region of Enrollment
United States
167 participants200 participants33 participants
Sex: Female, Male
Female
122 Participants141 Participants19 Participants
Sex: Female, Male
Male
45 Participants59 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1670 / 33
serious
Total, serious adverse events
0 / 1670 / 33

Outcome results

Primary

Sustained Silent Reading Speed

Time frame: 30 minutes

ArmMeasureValue (MEAN)Dispersion
Dry EyeSustained Silent Reading Speed248.4 words/minuteStandard Deviation 79.5
ControlsSustained Silent Reading Speed270.3 words/minuteStandard Deviation 75.3
Secondary

Change in Tear Osmolarity

Time frame: Before and after 30 minutes reading

ArmMeasureValue (MEAN)Dispersion
Dry EyeChange in Tear Osmolarity2.7 mOsm/LStandard Deviation 12.3
ControlsChange in Tear Osmolarity1.8 mOsm/LStandard Deviation 10.9
Secondary

Change in Total Ocular Staining Score (OSS)

Ocular staining score (OSS) is sum of the corneal and conjuctival staining scores with a total possible maximum score of 12 for each eye. Corneal staining is graded with a maximum possible fluorescein score of 6 for each cornea (the punctate epithelial erosions grade between 0-3 plus any extra points for modifiers up to 3). Nasal and temporal conjunctiva are graded separately with a score range between 0 and 3 for each area after instillation of lissamine green. An abnormal OSS is defined as being a total score of 3 or more.

Time frame: Before and after 30 minutes reading

ArmMeasureValue (MEAN)Dispersion
Dry EyeChange in Total Ocular Staining Score (OSS)1.5 units on a scaleStandard Deviation 1.4
ControlsChange in Total Ocular Staining Score (OSS)1.1 units on a scaleStandard Deviation 1.2
Secondary

Change in Visual Acuity

Time frame: 30 minutes

ArmMeasureValue (MEAN)Dispersion
Dry EyeChange in Visual Acuity0.02 logMARStandard Deviation 0.07
ControlsChange in Visual Acuity0.02 logMARStandard Deviation 0.09
Secondary

Cytokines

Identification of various inflammatory cytokines in tear film of dry eye patients comparing to controls.

Time frame: Tear samples were collected on the day of the exam. The samples were frozen to be assayed upon completion of the study.

Population: The cytokine analysis was performed in the samples of selected participants based on their clinical signs and characteristics. The sample size of the groups was justified using the power analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Dry EyeCytokinesIFNg99.79 pg/mLStandard Error 16.81
Dry EyeCytokinesIL8903.91 pg/mLStandard Error 268.02
Dry EyeCytokinesTNFa131.16 pg/mLStandard Error 54.63
Dry EyeCytokinesIL6130.78 pg/mLStandard Error 39.65
Dry EyeCytokinesIL17A176.08 pg/mLStandard Error 28.39
Dry EyeCytokinesIL1b27.40 pg/mLStandard Error 5.09
Dry EyeCytokinesIL10211.69 pg/mLStandard Error 30.37
Dry EyeCytokinesIL12p7070.89 pg/mLStandard Error 10.06
ControlsCytokinesIL12p70131.32 pg/mLStandard Error 28.59
ControlsCytokinesIL1b27.87 pg/mLStandard Error 6.47
ControlsCytokinesIL17A200.00 pg/mLStandard Error 41.42
ControlsCytokinesIFNg150.10 pg/mLStandard Error 30.29
ControlsCytokinesIL10304.29 pg/mLStandard Error 55.01
ControlsCytokinesTNFa107.53 pg/mLStandard Error 25.3
ControlsCytokinesIL8157.58 pg/mLStandard Error 32.39
ControlsCytokinesIL669.64 pg/mLStandard Error 13.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026